Contact information Verified work emails, personal emails, and direct dials — unlocked in one click.
Work email
•••••@•••••.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••
Free to start · No credit card required
Current company Raregenix Consulting
Biotechnology Research · 4 employees · Founded 2024 · London, United Kingdom
RareGeniX: Advancing Rare Disease Therapeutics with Precision At RareGeniX, we specialise in transforming cutting-edge science into life-changing therapies for patients with rare diseases. As a trusted partner to innovators across the biopharmaceutical field, we provide the strategic and operational expertise needed to navigate the complexities of drug development. What We Do: We offer tailored solutions to accelerate your path from discovery to patient impact: • Preclinical & CMC Development – Translating scientific breakthroughs into scalable therapies • Early Regulatory Strategy – Proactive planning for a smoother approval journey • Risk-Based Quality Support – Mitigating challenges before they become roadblocks • Efficient Clinical and Medical Support – Optimizing studies for success in rare disease populations • Virtual Leadership – Providing experienced guidance without the overhead Who We Support: Our expertise benefits a diverse range of stakeholders in the rare disease space: • Venture & Private Equity firms – Evaluating and de-risking investments • Incubator-stage startups – Laying strong scientific and regulatory foundations • Emerging biotechs – Scaling innovation into viable development programs • Established organizations – Enhancing efficiency and strategic execution How We Work: At RareGeniX, we go beyond traditional consulting: • Integrated Partners – We work alongside your team, aligning with your vision and goals • Industry Experts – Deep experience in Global Regulatory Affairs, CMC, Quality, Clinical Development, and Patient Engagement • Development Accelerators – Smart, tailored strategies to streamline decision-making and execution • Patient-Driven Advocates – Every project is guided by our commitment to delivering real solutions for patients We don’t just advise—we collaborate, accelerate, and deliver. Rare disease drug development is complex, but with us, you’re equipped to navigate it with confidence.